RT Journal Article
SR Electronic
T1 Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008325corr1
DO 10.1136/jitc-2023-008325corr1
VO 12
IS 3
YR 2024
UL http://jitc.bmj.com/content/12/3/e008325corr1.abstract